Trial intelligence / Profile preview

Weekly Vinorelbine and Paclitaxel in Elderly Advanced NSCLC

NCT00602797Phase 2Completed

Sponsor
University of Nebraska
Start
Dec 2007
Primary completion
Aug 2014
Modality
Cytokines & Interferons, Small Molecules, Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 2 trial of vinorelbine, Paclitaxel Micelles for Injection in non-small cell lung cancer (NSCLC), sponsored by University of Nebraska. Started Dec 2007; status: completed.

02

Drugs

vinorelbinePaclitaxel Micelles for Injection
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT00602797.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00602797.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call